特发性血小板减少性紫癜(ITP)是临床最常见的出血性疾病,是一种获得性器官特异性自身免疫性疾病。我国目前尚无公认的ITP治疗指南,相当多的医院在一定程度上存在着过度治疗现象。长春市宽城区医院应用大剂量地塞米松联合亚临床剂量静丙球治疗ITP20例,取得满意的疗效,现报告如下 Idiopathic thrombocytopenic purpura (ITP) is the most common hemorrhagic disease in the clinic and is an acquired organ-specific autoimmune disease. At present, there is no recognized guideline for ITP treatment in our country. To a certain extent, a considerable number of hospitals have the phenomenon of over-treatment. Changchun City Kuancheng Hospital application of high-dose dexamethasone and subclinical dose of intravenous corticosteroid treatment of ITP20 cases, and achieved satisfactory results, are as follows